Laparoscopic resection of splenic flexure colon cancers: a retrospective multi-center study with 117 cases

Laparoscopic versus open surgery for left flexure colon cancer: A propensity score matched analysis from an international cohort

“…This result is in line with previous reports, which associated minimally invasive surgery with a more extensive lymphadenectomy [13,20].…”

“…No differences were found for specimen length and resection margins. Moreover, the median number of retrieved nodes was higher in the LapGroup ( This result is in line with previous reports, which associated minimally invasive surgery with a more extensive lymphadenectomy [13,20].…”

“…Few data on the feasibility and outcomes of laparoscopy for SFC are currently available in the literature, mainly from single-centre series with a small number of patients [13][14][15][16][17][18][19][20][21][22].…”

“…Patients' demographic and clinical data according to surgical approach after propensity score matching relevant confounding factors. The significant findings of our study are (i) that laparoscopic surgery is confirmed to be safe and feasible for elective resection of Stages I-III SFC; (ii) compared to open surgery, it is associated with better short-term outcomes; and (iii) that it allows comparable long-term oncological outcomes.Several single-centre studies based on small numbers of patients showed the feasibility of laparoscopy for SFC[13][14][15][16][17][18][19][20][21][22]. Looking at studies comparing laparoscopic and open surgery, Nakashima and colleagues [20] compared 33 patients who underwent laparoscopic surgery for SFC to 22 patients who underwent open surgery, demonstrating improved postoperative outcomes in the LapGroup.…”

Tips and tricks in laparoscopic management of left colonic vessels – a video vignette

“…During resection of the splenic flexure, as described in a multicentre study of 117 cases , the first step of our technique is the identification and the sealing of the left colic pedicle, using the energy device Ligasure Advance™ (Covidien, Mansfield, Massachusetts, USA), which combines monopolar tip dissection and a vessel sealer divider and is associated with reduced blood loss and operative time .…”